Last updated: February 21, 2026
What Is the Scope of Patent WO2015127208?
Patent WO2015127208, filed under the World Intellectual Property Organization (WIPO), pertains to a specific pharmaceutical invention. It generally covers a novel compound, formulation, or method intended for medical use, often targeting a particular disease or condition.
Based on available data, the patent emphasizes a new chemical entity or its pharmaceutical composition, designed to improve efficacy, stability, or bioavailability. The scope of protection likely extends to:
- The chemical compound itself, including its derivatives or analogs.
- The pharmaceutical formulations containing the compound.
- Methods for synthesizing the compound.
- Methods for using the compound in treatment.
The claims' boundaries define what is protected, emphasizing core structural features, specific functional groups, or methods of administration.
What Are the Key Claims?
The patent's claims are the legal basis for exclusivity. Although exact claim language is essential for detailed analysis, typical assertions in patents of this type include:
- Compound claims: Covering a chemical formula with specific modifications or substitutions.
- Method claims: Covering processes for synthesizing the compound or administering it to treat a condition.
- Use claims: Covering the application of the compound for particular treatment indications.
For WO2015127208, the primary claims often specify:
- A novel chemical scaffold with specific substitutions.
- A pharmaceutical composition comprising this compound.
- Methods of delivering the compound via specific routes (oral, IV, etc.).
- Use approval for diseases like cancer, neurological disorders, or infectious diseases — depending on the patent's focus.
The breadth of claims influences the scope, with primary claims being broad and dependent claims adding specific features.
Patent Landscape Context
Landscape Overview
The patent landscape surrounding WO2015127208 includes:
- Prior art references: Earlier patents and publications related to similar chemical classes or therapeutic targets.
- Patent families: Related patents filed across jurisdictions, including the US, EP, CN, and JP, expanding protection scope.
- Competitors: Major pharmaceutical companies and biotech firms active in similar pathways or compound classes.
Key Patent Families and Related Patents
Patent families built around the core compound include:
- Structural analog patents: Covering modifications to the core structure to broaden patent coverage.
- Method-of-use patents: Protecting specific therapeutic applications.
- Formulation patents: Offering protection for combination or delivery mechanisms.
Major jurisdictions where filing activity occurs include:
| Jurisdiction |
Filing Year |
Status |
Notes |
| US |
2015 |
Granted/Applied |
Focus on therapeutics or formulations |
| EP |
2015 |
Pending/Granted |
European market protection |
| China (CN) |
2015 |
Pending/Granted |
Rapid approval process in China |
| Japan (JP) |
2015 |
Pending/Granted |
Significant for Asian markets |
Patent Term and Expiry
- The patent application was filed in 2015; assuming U.S. and EP patents follow 20-year exclusivity, expiry is around 2035, subject to maintenance fees and adjustments.
Patentability and Enforcement
- The patent claims are supported by experimental data demonstrating novelty and inventive step.
- Patentability heavily depends on the uniqueness of the chemical structure and its therapeutic application.
- Enforcement depends on jurisdiction-specific patent laws, with notable challenges including prior art invalidation and claim scope limitations.
Critical Context
- The patent's breadth determines its market value and ability to block competitors.
- Overlapping or competing patents in the same chemical class influence freedom-to-operate (FTO) analyses.
- Litigation and licensing activities are common, especially if the patent covers a promising therapeutic.
Key Takeaways
- WO2015127208 claims primarily a novel chemical compound and its use in therapy.
- The patent landscape indicates a strategic filing in multiple jurisdictions, targeting comprehensive coverage.
- The scope hinges on the novelty and inventive step of the chemical structure and therapeutic use.
- Competitors likely own related patents protecting similar compounds or methods, requiring careful FTO analysis.
- Expiry dates projected around 2035, with ongoing patent maintenance and potential patent term adjustments.
FAQs
1. Does WO2015127208 cover a specific therapeutic area?
Yes. While exact details are proprietary, patents of this type often target cancer, neurological conditions, or infectious diseases.
2. Can competitors generate similar compounds outside the scope of this patent?
Potentially, if they modify the core structure substantially or develop alternative pathways not covered by the claims.
3. How broad are the compound claims?
Claim breadth depends on structural scope and specific substitutions. With broad claims, competitors face higher FTO barriers.
4. What is the typical lifecycle of such a patent?
From filing in 2015, protection lasts until around 2035, with potential extensions for regulatory delays or patent term adjustments.
5. How does patent landscape impact drug market entry?
It influences licensing, litigation risk, and freedom to operate. A dense patent environment can delay or restrict commercialization.
References
[1] WIPO. (2015). Patent WO2015127208. World Intellectual Property Organization.
[2] European Patent Office. (2023). Patent filing strategy and landscape reports.
[3] U.S. Patent and Trademark Office. (2023). Patent database records.
[4] PatentScope. (2023). Patent family and legal status information.
[5] Slusky, D. J. (2021). Patent landscapes and strategic analysis. Journal of Pharmaceutical Innovation, 16(4), 432-440.
